Cancer & Therapeutics

Cancer Therapeutics aims to address the challenges of tumour heterogeneity, cancer development, and drug resistance by utilising a growing number of technologies available to doctors in the treatment of this illness. It has gone through a paradigm shift away from classic cytotoxic medications and toward targeting proteins that are fundamental to the cancer phenotype. The discovery and development of HSP90 inhibitors has been sought by cancer therapies as a means of avoiding or overcoming medication resistance. All anticancer drugs work by inhibiting cell growth or normal function, DNA synthesis, and RNA and protein metabolite blocking or alteration.

  • Cancer stem cells
  • Kinase inhibitors
  • Personalised medicine
  • Protein–protein interactions

    Related Conference of Cancer & Therapeutics

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Cancer & Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in